RecruitingNCT06781437
Retrospective Observational Study of Italian Cohort of Lymphoma Patients (RETRO-LYMPH)
Studio Osservazionale Retrospettivo Di Coorte Italiana Di Pazienti Con Linfoma (RETRO-LYMPH)
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Enrollment
5,500 participants
Start Date
Feb 1, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
observational, non-interventional, retrospective, single-center study focusing on patients with lymphoma / lymphoproliferative syndrome between January 1980 and September 2021
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Age greater than or equal to 18 years of enrollment
- Diagnosis of lymphoma or lymphoproliferative syndrome between January 1980 and September 2021
- Signature of the informed consent form where applicable
Exclusion Criteria1
- none
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06781437
Related Trials
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
NCT0685942413 locations
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
NCT0233266817 locations
Rituximab Plus Venetoclax in Front Line Marginal Zone Lymphoma
NCT065103091 location
Dietary and Topical Magnesium Replacement or Supplementation in Patients With Lymphoma
NCT052943671 location
Odronextamab in Low Tumor Volume Advanced FL
NCT071286411 location